Filing Details
- Accession Number:
- 0001437749-21-027397
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-24 16:46:52
- Reporting Period:
- 2021-11-22
- Accepted Time:
- 2021-11-24 16:46:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1389545 | Novabay Pharmaceuticals Inc. | NBY | Pharmaceutical Preparations (2834) | 680454536 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1738781 | Audrey Kunin | C/O Novabay Pharmaceuticals, Inc. 2000 Powell Street, Suite 1150 Emeryville CA 94608 | Chief Product Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-22 | 25,000 | $0.46 | 25,000 | No | 4 | P | Indirect | see footnote |
| Common Stock | Acquisiton | 2021-11-23 | 66,133 | $0.46 | 91,133 | No | 4 | P | Indirect | see footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | see footnote |
| No | 4 | P | Indirect | see footnote |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $0.4545 to $0.4610. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.
Billionaire Hedge Funds
